Breaking News

PSI CRO Appoints Regulatory Affairs Head

By Kristin Brooks | February 26, 2014

Schmoetzer brings extensive industry experience

Dr. Gabriele Schmoetzer has been appointed head of regulatory affairs, Germany, at PSI CRO. Dr. Schmoetzer will supervise all regulatory-related activities for Germany, Austria and Switzerland.
 
Dr. Schmoetzer brings 24 years of clinical research experience, having worked for small, mid-size and large CROs. She has held positions in international and global project management, regulatory affairs, where she has held managerial positions, and has been responsible for clinical trial submissions in Germany and a number of other EU countries. Dr. Schmoetzer has experience with RA-specific processes and brings both technical expertise and extensive knowledge of the clinical trial regulatory environment.

blog comments powered by Disqus
  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • Moore’s Law for More Health

    Moore’s Law for More Health

    Patrick Jordan , Encore Health Resources||June 2, 2015
    This year marks the semicentennial anniversary of a prediction about exponential growth and productivity

  • Applying Risk-Based Monitoring in the Real World

    Applying Risk-Based Monitoring in the Real World

    Lynn King, TKL Research||June 2, 2015
    Implementing an acceptable clinical monitoring plan requires a thorough understanding of the new rules under which we’re operating